Zenith Epigenetics Announces Grant of U.S. Food and Drug Administration Fast Track Designation for ZEN-3694 in NUT Carcinoma Calgary, Alberta–(Newsfile Corp. – July 14, 2025) – Zenith Epigenetics Ltd. (“Zenith” or the “Company”) is pleased to announce the designation of ZEN-3694 as a Fast Track product by the U.S. Food …
Read More »
Matribhumi Samachar English